Global Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Global Flu Vaccine Supply, Demand and Key Producers, 2023-2029

The global Flu Vaccine market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

This report studies the global Flu Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Flu Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Flu Vaccine total production and demand, 2018-2029, (M Doses)

Global Flu Vaccine total production value, 2018-2029, (USD Million)

Global Flu Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)

Global Flu Vaccine consumption by region & country, CAGR, 2018-2029 & (M Doses)

U.S. VS China: Flu Vaccine domestic production, consumption, key domestic manufacturers and share

Global Flu Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (M Doses)

Global Flu Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (M Doses)

Global Flu Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (M Doses).

This reports profiles key players in the global Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Flu Vaccine market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/Doses) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Flu Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Flu Vaccine Market, Segmentation by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Global Flu Vaccine Market, Segmentation by Application
6 Months to 3 Years
> 3 Years

Companies Profiled:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Key Questions Answered

1. How big is the global Flu Vaccine market?

2. What is the demand of the global Flu Vaccine market?

3. What is the year over year growth of the global Flu Vaccine market?

4. What is the production and production value of the global Flu Vaccine market?

5. Who are the key producers in the global Flu Vaccine market?